Promising Healthcare Stocks To Follow Today – January 30th
by Michael Walen · The Markets DailyUnitedHealth Group, Johnson & Johnson, and Medtronic are the three Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares of publicly traded companies that operate in the healthcare sector—including pharmaceutical and biotechnology firms, medical-device makers, hospitals and clinics, health insurers, and other providers of medical services and supplies. Investors buy them to gain exposure to healthcare demand and innovation, but performance is strongly influenced by regulation, clinical trial outcomes, patent and reimbursement decisions, and demographic trends such as aging populations. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read Our Latest Research Report on UNH
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Read Our Latest Research Report on JNJ
Medtronic (MDT)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Read Our Latest Research Report on MDT
See Also
- MarketBeat’s Top Five Stocks to Own in January 2026
- Palantir Bulls Face a Reality Check Before Earnings
- Starbucks Gets a Jolt After Earnings, But Will the Buzz Last?
- Netflix Just Set a Hard Low—Is This The Start of a 40% Rally?
- Physical AI: The Next Industrial Revolution Is Finally Here
- Apple Posts Record Quarter, But AI Details Remain Unclear